Gw pharmaceuticals plc (GWPH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Revenues
Total revenues

120,633

109,076

90,971

72,038

39,247

6,654

2,420

3,284

3,041

3,992

Operating expenses
Cost of product sales

10,769

7,298

8,150

6,620

5,131

1,829

1,399

1,791

1,625

1,171

Research and development

45,874

43,535

36,301

32,467

30,375

29,086

28,943

45,113

43,485

36,195

Selling, general and administrative

71,183

78,351

64,178

62,273

55,078

49,083

52,685

37,786

26,173

25,174

Total operating expenses

127,826

129,184

108,629

101,360

90,584

79,998

83,027

84,690

71,283

62,540

Loss from operations

-7,193

-20,108

-17,658

-29,322

-51,337

-73,344

-80,607

-81,406

-68,242

-58,548

Interest income

1,269

1,818

2,249

2,310

2,087

2,449

1,283

999

759

604

Interest expense

284

282

272

268

265

295

297

313

325

314

Other income

-

-

-

104,117

-

0

-

-

-

-

Foreign exchange loss

-20

-5,073

1,889

2,026

-1,114

-982

-823

-3,660

-640

160

Loss before income taxes

-6,228

-23,645

-13,792

78,863

-50,629

-72,172

-80,444

-84,380

-68,448

-58,098

Income tax expense (benefit)

1,737

1,301

-35

-885

-565

-266

-565

-369

1,013

3,718

Net loss

-7,965

-24,946

-13,757

79,748

-50,064

-71,906

-79,879

-84,011

-69,461

-61,816

Net loss per share:
Basic

-0.02

-

-0.04

0.21

-0.14

-

-0.23

-0.25

-

-

Diluted

-0.02

-

-0.04

0.21

-0.14

-

-0.23

-0.25

-

-

Weighted average shares outstanding:
Basic

373,831

-

372,246

371,712

369,823

-

341,302

340,457

-

-

Diluted

373,831

-

372,246

377,435

369,823

-

341,302

340,457

-

-

Net loss per common share, basic and diluted

-

-

-

-

-

-0.20

-

-

-0.20

-0.20

Weighted average common shares outstanding, basic and diluted

-

-

-

-

-

366,458

-

-

340

313,730

Product Net Sales
Total revenues

120,532

109,019

90,849

71,489

38,974

6,617

2,343

3,094

2,812

2,220

Other Revenue
Total revenues

101

57

122

549

273

37

77

190

229

1,772